학술논문
2BA - Randomised phase 3 study of S-1 versus capecitabine, with bevacizumab optional in both arms, in the first-line treatment of metastatic colorectal cancer (mCRC), the SALTO study of the Dutch Colorectal Cancer Group
Document Type
Abstract
Author
Source
In European Journal of Cancer February 2017 72 Supplement 1:S5-S5
Subject
Language
ISSN
0959-8049